Eugene Lin1, Manjula Kurella Tamura1,2, Maria E Montez-Rath1, Glenn M Chertow1. 1. Division of Nephrology, Stanford University School of Medicine, Palo Alto, California, USA. 2. Geriatric Research and Education Clinical Center, Palo Alto VA Health Care System, Palo Alto, California, USA.
Abstract
INTRODUCTION: The use of administrative data to capture 30-day readmission rates in end-stage renal disease is challenging since Medicare combines claims from acute care, inpatient rehabilitation (IRF), and long-term care hospital stays into a single "Inpatient" file. For data prior to 2012, the United States Renal Data System does not contain the variables necessary to easily identify different facility types, making it likely that prior studies have inaccurately estimated 30-day readmission rates. METHODS: For this report, we developed two methods (a "simple method" and a "rehabilitation-adjusted method") to identify acute care, IRF, and long-term care hospital stays from United States Renal Data System claims data, and compared them to methods used in previously published reports. FINDINGS: We found that prior methods overestimated 30-day readmission rates by up to 12.3% and overestimated average 30-day readmission costs by up to 11%. In contrast, the simple and rehabilitation-adjusted methods overestimated 30-day readmission rates by 0.1% and average 30-day readmission costs by 1.8%. The rehabilitation-adjusted method also accurately identified 96.8% of IRF stays. DISCUSSION: Prior research has likely provided inaccurate estimates of 30-day readmissions in patients undergoing dialysis. In the absence of data on specific facility types particularly when using data prior to 2012, future researchers could employ our method to more accurately characterize 30-day readmission rates and associated outcomes in patients with end-stage renal disease.
INTRODUCTION: The use of administrative data to capture 30-day readmission rates in end-stage renal disease is challenging since Medicare combines claims from acute care, inpatient rehabilitation (IRF), and long-term care hospital stays into a single "Inpatient" file. For data prior to 2012, the United States Renal Data System does not contain the variables necessary to easily identify different facility types, making it likely that prior studies have inaccurately estimated 30-day readmission rates. METHODS: For this report, we developed two methods (a "simple method" and a "rehabilitation-adjusted method") to identify acute care, IRF, and long-term care hospital stays from United States Renal Data System claims data, and compared them to methods used in previously published reports. FINDINGS: We found that prior methods overestimated 30-day readmission rates by up to 12.3% and overestimated average 30-day readmission costs by up to 11%. In contrast, the simple and rehabilitation-adjusted methods overestimated 30-day readmission rates by 0.1% and average 30-day readmission costs by 1.8%. The rehabilitation-adjusted method also accurately identified 96.8% of IRF stays. DISCUSSION: Prior research has likely provided inaccurate estimates of 30-day readmissions in patients undergoing dialysis. In the absence of data on specific facility types particularly when using data prior to 2012, future researchers could employ our method to more accurately characterize 30-day readmission rates and associated outcomes in patients with end-stage renal disease.
Authors: Navdeep Tangri; Dana C Miskulin; Jing Zhou; Karen Bandeen-Roche; Wieneke M Michels; Patti L Ephraim; Aidan McDermott; Deidra C Crews; Julia J Scialla; Stephen M Sozio; Tariq Shafi; Bernard G Jaar; Klemens Meyer; L Ebony Boulware Journal: Nephrol Dial Transplant Date: 2014-11-02 Impact factor: 5.992
Authors: Rajiv Saran; Yi Li; Bruce Robinson; John Ayanian; Rajesh Balkrishnan; Jennifer Bragg-Gresham; Joline T L Chen; Elizabeth Cope; Debbie Gipson; Kevin He; William Herman; Michael Heung; Richard A Hirth; Steven S Jacobsen; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Alan B Leichtman; Yee Lu; Miklos Z Molnar; Hal Morgenstern; Brahmajee Nallamothu; Ann M O'Hare; Ronald Pisoni; Brett Plattner; Friedrich K Port; Panduranga Rao; Connie M Rhee; Douglas E Schaubel; David T Selewski; Vahakn Shahinian; John J Sim; Peter Song; Elani Streja; Manjula Kurella Tamura; Francesca Tentori; Paul W Eggers; Lawrence Y C Agodoa; Kevin C Abbott Journal: Am J Kidney Dis Date: 2015-07 Impact factor: 8.860
Authors: Guofen Yan; Keith C Norris; Tom Greene; Alison J Yu; Jennie Z Ma; Wei Yu; Alfred K Cheung Journal: Clin J Am Soc Nephrol Date: 2014-06-19 Impact factor: 8.237
Authors: Eugene Lin; Khristina I Lung; Glenn M Chertow; Jay Bhattacharya; Darius Lakdawalla Journal: Value Health Date: 2021-07-30 Impact factor: 5.101